שולי רווח נקי: RedHill (RDHL)

סמל מסחרי של RedHill Biopharma (RDHL)

While RedHill Biopharma (RDHL) staff are motivated by RSU plans for scientific achievements, management is focusing on international licensing and cost reduction. The net margin of trading and production activities clearly links these approaches, where the parameter value reaches 0.00. Stable demand for gastrointestinal drugs generates revenue, however, the company's significant debts substantially limit the final net profit.

שולי רווח נקי RedHill Biopharma Ltd (RDHL): לתקופה 04.07.2022 - 20.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור redhillbio.com (RDHL)

- שער מניה ותחזית מחירי מומחים:
ניתוח כל מדדי החברה:RedHill Biopharma
סחורת הדגל של RedHill Biopharma

Sales margins determine the share of net profit in every dollar of revenue, reflecting the overall efficiency of the business. GURU.Markets tools visualize this trend through net profit margins, where the current value is 0.00. This metric is calculated as the ratio of the final financial result to total revenue. For RedHill Biopharma (RDHL), calculations depend on R&D expenditures. The absence of heavy manufacturing minimizes environmental costs, simplifying the expense structure.